ES471895A1 - Procedimiento para preparar derivados de benzamidina - Google Patents

Procedimiento para preparar derivados de benzamidina

Info

Publication number
ES471895A1
ES471895A1 ES471895A ES471895A ES471895A1 ES 471895 A1 ES471895 A1 ES 471895A1 ES 471895 A ES471895 A ES 471895A ES 471895 A ES471895 A ES 471895A ES 471895 A1 ES471895 A1 ES 471895A1
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
image
compounds
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471895A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARON SA
Original Assignee
ARON SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARON SA filed Critical ARON SA
Publication of ES471895A1 publication Critical patent/ES471895A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para preparar derivados de benzamidina de fórmula: **(Fórmula 01)** en la que R1, R2, R3 representan independientemente entre sí, un átomo de hidrógeno, un átomo de halógeno, un grupo trifluorometilo, un grupo nitro o un grupo alcoxi en C1-C4 o un grupo alquilo en C1-C4; R4 representa un radical de fórmula: **(Fórmula 02)** en donde R5 representa un átomo de hidrógeno, un grupo alquilo en C1-C4, un grupo fenilo o halofenilo.
ES471895A 1977-07-20 1978-07-20 Procedimiento para preparar derivados de benzamidina Expired ES471895A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB30523/77A GB1587945A (en) 1977-07-20 1977-07-20 Benzamidine derivatives

Publications (1)

Publication Number Publication Date
ES471895A1 true ES471895A1 (es) 1979-10-01

Family

ID=10309001

Family Applications (2)

Application Number Title Priority Date Filing Date
ES471895A Expired ES471895A1 (es) 1977-07-20 1978-07-20 Procedimiento para preparar derivados de benzamidina
ES479110A Expired ES479110A1 (es) 1977-07-20 1979-03-30 Procedimiento para preparar derivados de benzamidina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES479110A Expired ES479110A1 (es) 1977-07-20 1979-03-30 Procedimiento para preparar derivados de benzamidina.

Country Status (16)

Country Link
US (1) US4246272A (es)
JP (1) JPS5452077A (es)
AT (1) AT359491B (es)
AU (1) AU516005B2 (es)
BE (1) BE868659A (es)
CA (1) CA1095055A (es)
CH (1) CH633000A5 (es)
DE (1) DE2831457A1 (es)
ES (2) ES471895A1 (es)
FR (1) FR2398066A1 (es)
GB (1) GB1587945A (es)
IL (1) IL55088A (es)
IT (1) IT1107844B (es)
NL (1) NL7807679A (es)
SE (1) SE447249B (es)
ZA (1) ZA783830B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943634A (en) * 1980-09-16 1990-07-24 Eli Lilly And Company N-heterocyclic benzamides
US4636243A (en) * 1980-09-16 1987-01-13 Eli Lilly And Company Benzamides, compositions and agricultural method
US5086184A (en) * 1980-09-16 1992-02-04 Dowelanco N-heterocyclic benzamides
US4416683A (en) * 1980-09-16 1983-11-22 Eli Lilly And Company Benzamides, compositions and agricultural method
IL165365A0 (en) 2004-11-24 2006-01-15 Q Core Ltd Finger-type peristaltic pump

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1668851B2 (de) * 1963-03-22 1973-05-03 Amidine und verfahren zu ihrer herstellung
GB1267009A (es) * 1969-07-25 1972-03-15
CA1039308A (en) * 1974-10-02 1978-09-26 James R. Mccarthy (Jr.) N,n'-disubstituted halophenylacetamidines and n,n'-disubstituted benzamidines

Also Published As

Publication number Publication date
JPS6223751B2 (es) 1987-05-25
ZA783830B (en) 1979-07-25
AT359491B (de) 1980-11-10
AU3808878A (en) 1980-01-17
ES479110A1 (es) 1979-07-01
BE868659A (fr) 1979-01-02
IL55088A0 (en) 1978-09-29
SE7807881L (sv) 1979-01-21
FR2398066A1 (fr) 1979-02-16
IT7868716A0 (it) 1978-07-19
US4246272A (en) 1981-01-20
IT1107844B (it) 1985-12-02
CA1095055A (en) 1981-02-03
FR2398066B1 (es) 1980-09-26
AU516005B2 (en) 1981-05-14
DE2831457C2 (es) 1988-07-14
ATA497478A (de) 1980-04-15
DE2831457A1 (de) 1979-02-01
GB1587945A (en) 1981-04-15
JPS5452077A (en) 1979-04-24
NL7807679A (nl) 1979-01-23
IL55088A (en) 1981-07-31
CH633000A5 (fr) 1982-11-15
SE447249B (sv) 1986-11-03

Similar Documents

Publication Publication Date Title
DK114783D0 (da) Hidtil ukendte forbindelser, fremgangsmader til deres fremstilling samt deres anvendelse som laegemidler
GB0018272D0 (en) Chemical compounds IV
ES8700660A1 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ATE83773T1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
NO165072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-vinyl-og 3-ethynyl-8-carbolinderivater.
ES8401321A1 (es) Procedimiento para la obtencion de derivados de piridina.
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
ES471895A1 (es) Procedimiento para preparar derivados de benzamidina
ES449765A1 (es) Procedimiento para la preparacion de nuevas homoftalimidas.
ES8401456A1 (es) Procedimiento para la preparacion de 2-aminometilfenoles.
DE69808326D1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
NO811185L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater.
ES481298A1 (es) Un procedimiento para preparar nuevos benzotiazo-derivados.
ES448439A1 (es) Procedimiento para la preparacion de nuevos de diacina.
DE3271277D1 (en) Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
NO167201C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive semikarbazid-derivater.
SE8105297L (sv) Imidazolderivat